Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and improved formulations for existing drugs. The Company utilizes porous microparticle technology. The company's three initial product candidates are in clinical development. The lead product candidate is a cardiovascular drug in Phase III clinical development for the detection of coronary artery disease.
500 Arsenal Street
Watertown, MA 02472